30 S&P 500 Stocks That Rose In The Crisis: It’s A Market Of Stocks

I have long asserted that it is a market of stocks and not a stock market. Perhaps the veracity of that statement has never been clearer than it is today. We are all aware of the devastation to the stock market in general that the shutdown instigated by the coronavirus has cost. However, despite the general stock market fallout, an article in MarketWatch on April 1, 2020, featured 30 S&P 500 stocks that rose during the disastrous 1st quarter. The following FAST Graphs portfolio review lists those 30 stocks in order of lowest to highest valuation based on adjusted operating earnings P/E ratios.

(Click on image to enlarge)

Summary and Conclusions

This will be the first in a series of videos where I will reveal a cursory overview of these 30 risers that have gone against the grain. With this first video, I went from the lowest valuations to the highest valuations. In part 2 and part 3 I will be going up the valuation chain. In other words, the companies in part 2 will be comprised of companies with higher valuations, as will part 3. To be clear, none of these have been comprehensively researched. They are simply offered to provide a perspective of how vastly different individual stocks that comprise the market are, and how differently they perform even in a crisis like this.

FAST Graphs Analyze Out Loud Reviewing Biogen (BIIB), AmerisourceBergen (ABC), Gilead Sciences (GILD), Davita (DVA), JM Smucker (SJM), Progressive (PGR), Kellogg (K), T Mobile (TMUS), Regeneron (REGN), Akamai (AKAM)

Video Length: 00:14:12